American Public Education, Inc. (APEI) Income Statement

The revenue trajectory appears to have stabilized, with sequential growth from $158.3M in Q4 2025 to $171.7M in Q2 2026, suggesting that enrollment trends across APUS and nursing segments are firming. However, the growth rate remains modest compared to peers like PRDO (24.2% 1Y), indicating that APEI is not experiencing the same acceleration. The stabilization likely reflects the integration of Rasmussen and Hondros, but the lack of double-digit growth suggests that the company is still in a consolidation phase rather than a high-growth mode.

The gross margin has shown a clear upward trend from the low 50s in 2024 to the mid-50s in 2026, indicating that the company is achieving better cost efficiencies, likely from scaling online programs and optimizing campus-based nursing operations. However, the margin is still structurally lower than PRDO's, which reflects APEI's heavier mix of campus-based nursing education that requires physical infrastructure. The improvement suggests that management's integration efforts are yielding results, but the gap to the best-in-class peer highlights the inherent cost disadvantage of the campus model.

The operating leverage is evident as revenue grew only modestly (from $152.9M to $174.7M over the same period), yet operating income multiplied tenfold. This suggests that SG&A costs have been kept in check while gross profit expanded, indicating that the company is benefiting from fixed cost absorption. The Q2 2026 operating income is not disclosed, but the net income of $9.8M implies continued profitability. The margin expansion from 1.5% to 12.5% is a strong signal that the operational restructuring is paying off, though investors should monitor whether this is sustainable given the ongoing nursing faculty wage pressures.

The cost structure is dominated by SG&A, which includes marketing and administrative expenses, and it has been the primary lever for margin improvement. The decline in SG&A intensity from 44.7% to 42.4% indicates that the company is gaining operational efficiency, likely from consolidating back-office functions and optimizing marketing spend. However, the risk of rising nursing faculty wages could pressure COGS, which is not separately disclosed but is embedded in the gross margin. The company's ability to maintain this discipline will be critical to sustaining the margin gains.

The most significant inflection in the income statement history is the transition from the low-margin, low-profitability period of 2024 (operating margins of 1.5-3.4%) to the current level of 12.5% in Q1 2026. This was driven by a combination of revenue stabilization and cost discipline, particularly in SG&A. The Q2 2026 net income of $9.8M, despite the lack of operating income disclosure, suggests that the momentum continued. This inflection appears to be the result of the successful integration of Rasmussen and Hondros, which initially dragged margins but now seems to be contributing positively. The lasting impact is a more diversified revenue base and a leaner cost structure, though the sustainability depends on enrollment trends and faculty costs.